Universities and colleges
A recent study from researchers at the University of Virginia has made a groundbreaking discovery that could revolutionize cancer treatment. The team, led by F.R. Depontieu, has identified tumor-associated phosphopeptides that can be targeted by CD4(+) T cells, providing a new avenue for cancer immunotherapy. These phosphopeptides, which are
Universities and colleges
Scientists in the United States have reported a link between hepatitis B virus (HBV) infection and the development of liver cancer, specifically hepatocellular carcinoma (HCC). The HBV X protein (pX) is implicated as a weak oncogene or a cofactor in hepatocarcinogenesis. Research has shown that pX induces DNA re-replication, DNA
Universities and colleges
A study published in Carcinogenesis details the activation of thromboxane A(2) receptors, which induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells. Researchers at the University of Kentucky found that the activation of thromboxane A(2) receptor by its agonist I-BOP led to
Scientists
A recent study published in the journal Carcinogenesis has shed light on the enigmatic role of Ski in pancreatic cancer cells. According to the researchers at Fudan University in Shanghai, China, Ski, previously believed to be an oncogene contributing to tumor resistance to transforming growth factor-beta (TGF-beta), may have a
Scientists
Recent research in the Journal of Experimental Botany has shed light on the role of cell polarity in the migration of monospores from the red alga Porphyra yezoensis. The study, conducted by Li and colleagues at Hokkaido University, reveals that Ca2+ influx and phosphoinositide signalling are crucial for the establishment
Universities and colleges
Recent research published in the journal Molecular Cancer Therapeutics has shed light on the potential of GRN163L, a novel telomerase template antagonist, as a potential anticancer agent. The study, conducted by E.M. Goldblatt and colleagues at Indiana University's Medical Department, investigated the molecular effects of GRN163L in
Universities and colleges
Mutations in the Mitogen-activated protein kinase (MAPK) signaling pathway are commonly found in melanoma, colon cancer, and thyroid cancer. However, mutations in exon 2 of MEK1 and exon 7 of ERK2 have not been extensively investigated in these cancers. Researchers at Johns Hopkins University conducted a study to investigate the
Universities and colleges
Researchers from Ohio State University have discovered new curcumin analogues, FLLL11 and FLLL12, which exhibit enhanced growth-suppressive activity and inhibit key cancer-promoting pathways in breast and prostate cancer cells. The study reveals that these analogues are more potent than curcumin in inhibiting cell viability, cell migration, and colony formation in
Universities and colleges
Scientists in Clayton, Australia, have made significant discoveries about the roles of reactive oxygen species (ROS) in regulating endothelial cell proliferation and apoptosis, shedding light on the complex processes of carcinogenesis and tumor progression. The findings, published in Naunyn - Schmiedebergs Archives of Pharmacology, reveal that Nox4-derived H2O2 activates ERK1/
Habitat destruction
Researchers from the University of British Columbia in Vancouver, Canada have made significant progress in understanding the pathobiology and prognosis of peripheral T-cell lymphomas. A recent collaborative project, the International Peripheral T-Cell Lymphoma Project, shed light on the clinico-pathologic and geographic differences of this diverse group of diseases. The study
Universities and colleges
Researchers from Gunma University in Maebashi, Japan, have identified a significant association between CD4+ T cell responses and wild-type p53 peptides in patients with squamous cell carcinoma of the head and neck (SCCHN). The study, published in Cancer Immunology, Immunotherapy, found that 57.9% of patients with HLA-DP5+ had detectable
Habitat destruction
Recent research published in the August issue of the journal Cancer Cell by Cell Press has identified an unexpected vulnerability in deadly melanoma cells. The study reveals that melanoma cells retain the ability to recognize and respond to double-stranded RNA (dsRNA), which can be exploited to induce an immune response
